Safety and efficacy of the FOLFOX regimen in patients with metastatic gastrointestinal cancers and severe hyperbilirubinemia: A real‑world experience
Oncology Letters · 30.10.2026 · 32 (6) · 1-9
DOI: 10.3892/ol.2026.15932 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 30.10.2026. Verfasst von Kadriye Başkurt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Etlik City Hospital, Ankara 06170, Türkiye. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Etlik City Hospital, Ankara 06170, Türkiye.
- Department of Medical Oncology, Gazi University, Ankara 06500, Türkiye.
- Department of Medical Oncology, TOBB University of Economics and Technology Hospital, Ankara 06510, Türkiye.
Zitieren
APA
Başkurt, K., Uyar, G. C., Yeşilbaş, E., Haznedaroğlu, E., Yücel, K. B., Sütcüoğlu, O., & Kaya, D. M. (2026). Safety and efficacy of the FOLFOX regimen in patients with metastatic gastrointestinal cancers and severe hyperbilirubinemia: A real‑world experience. Oncology Letters, 32(6), 1-9. https://doi.org/10.3892/ol.2026.15932
Vancouver
Başkurt K, Uyar GC, Yeşilbaş E, Haznedaroğlu E, Yücel KB, Sütcüoğlu O, et al. Safety and efficacy of the FOLFOX regimen in patients with metastatic gastrointestinal cancers and severe hyperbilirubinemia: A real‑world experience. Oncology Letters. 2026;32(6):1-9. doi:10.3892/ol.2026.15932
BibTeX
@article{Bakurt2026,
author = {Başkurt, Kadriye and Uyar, Galip Can and Yeşilbaş, Enes and Haznedaroğlu, Elif and Yücel, Kadriye Bir and Sütcüoğlu, Osman and Kaya, Dilsa Mizrak},
title = {Safety and efficacy of the FOLFOX regimen in patients with metastatic gastrointestinal cancers and severe hyperbilirubinemia: A real‑world experience},
journal = {Oncology Letters},
year = {2026},
volume = {32},
number = {6},
pages = {1--9},
doi = {10.3892/ol.2026.15932}
}
EUVIMED